Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I
- PMID: 16170086
- PMCID: PMC1739364
- DOI: 10.1136/jnnp.2004.050005
Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I
Abstract
Objective: To assess the prevalence of severe fatigue and its relation to functional impairment in daily life in patients with relatively common types of neuromuscular disorders.
Methods: 598 patients with a neuromuscular disease were studied (139 with facioscapulohumeral dystrophy, 322 with adult onset myotonic dystrophy, and 137 with hereditary motor and sensory neuropathy type I). Fatigue severity was assessed with Checklist Individual Strength (CIS-fatigue). Functional impairments in daily life were measured with the short form 36 item health questionnaire (SF-36).
Results: The three different neuromuscular patient groups were of similar age and sex. Severe experienced fatigue was reported by 61-74% of the patients. Severely fatigued patients had more problems with physical functioning, social functioning, mental health, bodily pain, and general health perception. There were some differences between the three disorders in the effects of fatigue.
Conclusions: Severe fatigue is reported by the majority of patients with relatively common types of neuromuscular disorders. Because experienced fatigue severity is associated with the severity of various functional impairments in daily life, it is a clinically and socially relevant problem in this group of patients.
Similar articles
-
Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.Eur Neurol. 2006;56(1):24-30. doi: 10.1159/000095137. Epub 2006 Aug 17. Eur Neurol. 2006. PMID: 16914927
-
Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.Acta Neurol Scand. 2007 Apr;115(4):265-70. doi: 10.1111/j.1600-0404.2006.00737.x. Acta Neurol Scand. 2007. PMID: 17376125
-
The development of a model of fatigue in neuromuscular disorders: a longitudinal study.J Psychosom Res. 2007 May;62(5):571-9. doi: 10.1016/j.jpsychores.2006.11.014. J Psychosom Res. 2007. PMID: 17467412
-
Fatigue and neuromuscular diseases.Ann Readapt Med Phys. 2006 Jul;49(6):289-300, 375-84. doi: 10.1016/j.annrmp.2006.04.015. Epub 2006 Apr 25. Ann Readapt Med Phys. 2006. PMID: 16780988 Review. English, French.
-
Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.Am J Hosp Palliat Care. 2006 Oct-Nov;23(5):412-6. doi: 10.1177/1049909106292169. Am J Hosp Palliat Care. 2006. PMID: 17060310 Review.
Cited by
-
Effectiveness and cost-effectiveness of a self-management group program to improve social participation in patients with neuromuscular disease and chronic fatigue: protocol of the Energetic study.BMC Neurol. 2015 Apr 19;15:58. doi: 10.1186/s12883-015-0314-4. BMC Neurol. 2015. PMID: 25913823 Free PMC article. Clinical Trial.
-
Pain in Spinal Muscular Atrophy: A Questionnaire Study.Phys Ther Res. 2022;25(3):150-155. doi: 10.1298/ptr.E10201. Epub 2022 Dec 22. Phys Ther Res. 2022. PMID: 36819911 Free PMC article.
-
Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene: A Cross-Sectional Study of 24 Patients.Neurol Genet. 2024 Dec 5;10(6):e200214. doi: 10.1212/NXG.0000000000200214. eCollection 2024 Dec. Neurol Genet. 2024. PMID: 39651462 Free PMC article.
-
Ankle-foot orthoses for improving walking in adults with calf muscle weakness due to neuromuscular disorders.Cochrane Database Syst Rev. 2025 Jan 16;1(1):CD014871. doi: 10.1002/14651858.CD014871.pub2. Cochrane Database Syst Rev. 2025. PMID: 39817620
-
Patient-identified disease burden in facioscapulohumeral muscular dystrophy.Muscle Nerve. 2012 Dec;46(6):951-3. doi: 10.1002/mus.23529. Muscle Nerve. 2012. PMID: 23225386 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical